Evidence map›Paper›PMID 38413574›Full record

ArticleTranslational psychiatry2024

Nightmares share genetic risk factors with sleep and psychiatric traits.

Hanna M Ollila, Nasa Sinnott-Armstrong, Katri Kantojärvi, Martin Broberg, Teemu Palviainen, Samuel Jones, Vili Ripatti, Anita Pandit, Robin Rong, Kati Kristiansson and 8 more

Open access · goldAbstract read
In one paragraph

Article in Translational psychiatry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
6.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Dreaming conundrum.Journal of sleep research · 2025
    Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 8 institutions in 3 countries.

Hanna M OllilaInstitute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland.
Nasa Sinnott-Armstrong *Department of Genetics, School of Medicine, Stanford University, Stanford, CA, USA.
Katri Kantojärvi *Population Health, Finnish Institute for Health and Welfare, Helsinki, Finland.
Martin Broberg *Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland.ORCID 0000-0002-5419-9479
Teemu PalviainenInstitute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland.ORCID 0000-0002-7847-8384
Samuel JonesInstitute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland.ORCID 0000-0003-0153-922X
Vili RipattiInstitute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland.
Anita PanditDepartment of Biostatistics, School of Public Health, University of Michigan, Ann Arbor, MI, 48109, USA.
Robin RongDepartment of Biostatistics, School of Public Health, University of Michigan, Ann Arbor, MI, 48109, USA.
Kati KristianssonPopulation Health, Finnish Institute for Health and Welfare, Helsinki, Finland.ORCID 0000-0003-4688-107X
Nils SandmanDepartment of Psychology and Speech-Language Pathology, and Turku Brain and Mind Center, University of Turku, Turku, Finland.
Katja ValliDepartment of Psychology and Speech-Language Pathology, and Turku Brain and Mind Center, University of Turku, Turku, Finland.ORCID 0000-0002-5133-8664
Christer HublinFinnish Institute of Occupational Health, Helsinki, Finland.
Samuli RipattiInstitute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland.ORCID 0000-0002-0504-1202
Elisabeth WidenInstitute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland.ORCID 0000-0001-7108-2806
Jaakko KaprioInstitute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland.ORCID 0000-0002-3716-2455
Richa SaxenaCenter for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA. rsaxena@broadinstitute.org.
Tiina PaunioPopulation Health, Finnish Institute for Health and Welfare, Helsinki, Finland. tiina.paunio@helsinki.fi.ORCID 0000-0002-5560-0666
University of Helsinki · FIBroad Institute · USUniversity of Michigan · USUniversity of Turku · FIFinnish Institute for Health and Welfare · FIFinnish Institute of Occupational Health · FIHelsinki University Hospital · FIStanford University · US

Funding

Genetics of chronotype and impact on metabolic diseaseR01DK107859 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI Richa Saxena · 2016 to 2026
$4.0M
Long COVID as a putative subtype of chronic fatigue syndromeR01AI170850 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI Richa Saxena · 2022 to 2026
$2.2M
NIAID NIH HHS R01 AI170850NIDDK NIH HHS R01 DK107859Wellcome Trust
6 · The paper itself

Abstract

Nightmares are vivid, extended, and emotionally negative or negative dreams that awaken the dreamer. While sporadic nightmares and bad dreams are common and generally harmless, frequent nightmares often reflect underlying pathologies of emotional regulation. Indeed, insomnia, depression, anxiety, or alcohol use have been associated with nightmares in epidemiological and clinical studies. However, the connection between nightmares and their comorbidities are poorly understood. Our goal was to examine the genetic risk factors for nightmares and estimate correlation or causality between nightmares and comorbidities. We performed a genome-wide association study (GWAS) in 45,255 individuals using a questionnaire-based assessment on the frequency of nightmares during the past month and genome-wide genotyping data. While the GWAS did not reveal individual risk variants, heritability was estimated at 5%. In addition, the genetic correlation analysis showed a robust correlation (rg > 0.4) of nightmares with anxiety (rg = 0.671, p = 7.507e-06), depressive (rg = 0.562, p = 1.282e-07) and posttraumatic stress disorders (rg = 0.4083, p = 0.0152), and personality trait neuroticism (rg = 0.667, p = 4.516e-07). Furthermore, Mendelian randomization suggested causality from insomnia to nightmares (beta = 0.027, p = 0.0002). Our findings suggest that nightmares share genetic background with psychiatric traits and that insomnia may increase an individual's liability to experience frequent nightmares. Given the significant correlations with psychiatric and psychological traits, it is essential to grow awareness of how nightmares affect health and disease and systematically collect information about nightmares, especially from clinical samples and larger cohorts.

Indexed as

DreamsSleep Initiation and Maintenance DisordersAnxiety DisordersGenome-Wide Association StudyHumansRisk Factors

Identifiers

PMID38413574
PMCPMC10899618
OpenAlexW4392200360

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.